# Forus

> Forus is a New York-based healthtech company (formerly Tandem Technology, Inc.) that runs an AI-powered network connecting doctors, pharmacies, payers, and biopharma to get prescribed medications to patients faster. Its software embeds in physician workflows and automates the administrative steps between a clinical decision and a patient starting treatment - prior authorization, benefit verification, financial assistance, and pharmacy routing. Free for doctors and patients, Forus earns revenue through pharmaceutical partnerships. Founded in 2023 by former Oscar Health product leader Sahir Jaggi, the company reached a reported $1 billion valuation in May 2026 with backing from Thrive Capital, General Catalyst, and Accel.

- **Founded:** 2023
- **Headquarters:** New York, New York, United States
- **Founders:** Sahir Jaggi (CEO & Founder)
- **Team size:** ~80 employees
- **Products:** Prior Authorization Automation, Benefit Verification, Appeal Letters, Enrollment Forms, Pharmacy Routing
- **Notable:** Reached a reported $1 billion valuation within roughly three years of founding (May 2026), Raised $160M total, including a $123M Series B led by Accel with Thrive Capital and General Catalyst, Signed five of the top 10 global pharmaceutical companies as partners

## Products & services

- **Prior Authorization Automation** — Automatically generates and submits prior authorization forms from the provider's EHR and determines the optimal approval pathway.
- **Benefit Verification** — Checks patient insurance coverage and eligibility in real time before treatment begins.
- **Appeal Letters** — Drafts and files appeals when authorizations are denied, reducing manual back-and-forth.
- **Enrollment Forms** — Completes and routes manufacturer and program enrollment forms for specialty therapies.
- **Pharmacy Routing** — Routes prescriptions to the right retail or specialty pharmacy and coordinates fulfillment.
- **Affordability Programs** — Matches patients to financial assistance and copay support programs to lower out-of-pocket cost.
- **PA Renewal Tracking & Patient Communication** — Tracks prior-authorization renewals and sends patients proactive status updates on approval and fulfillment.

## Achievements

- Reached a reported $1 billion valuation within roughly three years of founding (May 2026)
- Raised $160M total, including a $123M Series B led by Accel with Thrive Capital and General Catalyst
- Signed five of the top 10 global pharmaceutical companies as partners
- Grew roughly 10x annually for two consecutive years, largely via word-of-mouth
- Founder Sahir Jaggi named to Forbes 30 Under 30 Healthcare (2025)

## Latest updates

- **2026-05** — Forus announced $160M in total funding at a reported $1B valuation, including a $123M Series B led by Accel.
- **2026-05** — Forbes profiled Forus on the problem of unfilled prescriptions and the company's AI approach to fixing it.
- **2026-05** — CEO Sahir Jaggi appeared on TBPN to discuss why faster medication access matters.

## Links

- Website: https://forus.com
- LinkedIn: https://www.linkedin.com/company/forushq/
- Twitter/X: https://x.com/forus

---

Profile page: https://yespress.io/forus
Published by YesPress — https://yespress.io
Last updated: 2026-07-21